SU‐FF‐T‐104: Clinical Field Matching Using Intraoperative 90‐Y Brachytherapy Plaques

M. Folkert, T. Mauceri, M. Hollows, G. Chen

Research output: Contribution to journalArticle

Abstract

Purpose: A [formula omitted] foil in a semi‐cylindrical polycarbonate plaque has been developed and used to intraoperatively irradiate the dura for sarcomas of the spine in 16 patients. As smaller plaques are easier to place in restricted surgical fields, an investigation of field matching requirements was undertaken to evaluate the possibility of multiple site irradiations using small plaques. Method and Materials: Using a [formula omitted] brachytherapy treatment plaque and a cylindrical dosimetry phantom with the same radius, irradiations were performed using radiochromic film (GafChromic HS). 2 Gy was delivered, and the plaque was then moved to a position that would abut (0 mm) or overlap (1.5 mm, 3.0 mm, 4.5 mm, or 6.0 mm) with the previous plaque placement and an additional 2 Gy was delivered. Simulated field matching irradiations based on the plaque dose profile were also generated for 0 to 5 mm overlaps in 1 mm increments. Results: Measured peak % prescribed dose (%PD) and gap width below the 90% prescribed dose level (G90%) were determined to be −87% and 11.6 mm when abutting; −60% and 6.2 mm with 1.5 mm overlap; and −47% and 5.0 mm with 3.0 mm overlap. The dose profile was effectively flat with 4.5mm overlap and a peak overdosage of +34% was observed with 6.0 mm overlap. The simulated %PD and G90% were determined to be −84% and 9.5 mm when abutting; −77% and 8.2 mm with 1.0 mm overlap; −65% and 7.0 mm with 2.0 mm overlap; −45% and 5.0 mm with 3.0 mm overlap; and −17% and 2.5 mm with 4.0 mm overlap. A peak overdosage of +18% was observed with 5.0 mm overlap. Conclusion: A 5 mm plaque placement overlap provides for adequate field matching with the [formula omitted] plaque, improving its clinical utility and allowing for greater flexibility in the surgical environment.

Original languageEnglish (US)
Pages (from-to)2425
Number of pages1
JournalMedical Physics
Volume34
Issue number6
DOIs
StatePublished - 2007

Fingerprint

polycarbonate
Brachytherapy
Sarcoma
Spine
Therapeutics

ASJC Scopus subject areas

  • Biophysics
  • Radiology Nuclear Medicine and imaging

Cite this

SU‐FF‐T‐104 : Clinical Field Matching Using Intraoperative 90‐Y Brachytherapy Plaques. / Folkert, M.; Mauceri, T.; Hollows, M.; Chen, G.

In: Medical Physics, Vol. 34, No. 6, 2007, p. 2425.

Research output: Contribution to journalArticle

Folkert, M. ; Mauceri, T. ; Hollows, M. ; Chen, G. / SU‐FF‐T‐104 : Clinical Field Matching Using Intraoperative 90‐Y Brachytherapy Plaques. In: Medical Physics. 2007 ; Vol. 34, No. 6. pp. 2425.
@article{01d6075379d048338ba048240619caa2,
title = "SU‐FF‐T‐104: Clinical Field Matching Using Intraoperative 90‐Y Brachytherapy Plaques",
abstract = "Purpose: A [formula omitted] foil in a semi‐cylindrical polycarbonate plaque has been developed and used to intraoperatively irradiate the dura for sarcomas of the spine in 16 patients. As smaller plaques are easier to place in restricted surgical fields, an investigation of field matching requirements was undertaken to evaluate the possibility of multiple site irradiations using small plaques. Method and Materials: Using a [formula omitted] brachytherapy treatment plaque and a cylindrical dosimetry phantom with the same radius, irradiations were performed using radiochromic film (GafChromic HS). 2 Gy was delivered, and the plaque was then moved to a position that would abut (0 mm) or overlap (1.5 mm, 3.0 mm, 4.5 mm, or 6.0 mm) with the previous plaque placement and an additional 2 Gy was delivered. Simulated field matching irradiations based on the plaque dose profile were also generated for 0 to 5 mm overlaps in 1 mm increments. Results: Measured peak {\%} prescribed dose ({\%}PD) and gap width below the 90{\%} prescribed dose level (G90{\%}) were determined to be −87{\%} and 11.6 mm when abutting; −60{\%} and 6.2 mm with 1.5 mm overlap; and −47{\%} and 5.0 mm with 3.0 mm overlap. The dose profile was effectively flat with 4.5mm overlap and a peak overdosage of +34{\%} was observed with 6.0 mm overlap. The simulated {\%}PD and G90{\%} were determined to be −84{\%} and 9.5 mm when abutting; −77{\%} and 8.2 mm with 1.0 mm overlap; −65{\%} and 7.0 mm with 2.0 mm overlap; −45{\%} and 5.0 mm with 3.0 mm overlap; and −17{\%} and 2.5 mm with 4.0 mm overlap. A peak overdosage of +18{\%} was observed with 5.0 mm overlap. Conclusion: A 5 mm plaque placement overlap provides for adequate field matching with the [formula omitted] plaque, improving its clinical utility and allowing for greater flexibility in the surgical environment.",
author = "M. Folkert and T. Mauceri and M. Hollows and G. Chen",
year = "2007",
doi = "10.1118/1.2760760",
language = "English (US)",
volume = "34",
pages = "2425",
journal = "Medical Physics",
issn = "0094-2405",
publisher = "AAPM - American Association of Physicists in Medicine",
number = "6",

}

TY - JOUR

T1 - SU‐FF‐T‐104

T2 - Clinical Field Matching Using Intraoperative 90‐Y Brachytherapy Plaques

AU - Folkert, M.

AU - Mauceri, T.

AU - Hollows, M.

AU - Chen, G.

PY - 2007

Y1 - 2007

N2 - Purpose: A [formula omitted] foil in a semi‐cylindrical polycarbonate plaque has been developed and used to intraoperatively irradiate the dura for sarcomas of the spine in 16 patients. As smaller plaques are easier to place in restricted surgical fields, an investigation of field matching requirements was undertaken to evaluate the possibility of multiple site irradiations using small plaques. Method and Materials: Using a [formula omitted] brachytherapy treatment plaque and a cylindrical dosimetry phantom with the same radius, irradiations were performed using radiochromic film (GafChromic HS). 2 Gy was delivered, and the plaque was then moved to a position that would abut (0 mm) or overlap (1.5 mm, 3.0 mm, 4.5 mm, or 6.0 mm) with the previous plaque placement and an additional 2 Gy was delivered. Simulated field matching irradiations based on the plaque dose profile were also generated for 0 to 5 mm overlaps in 1 mm increments. Results: Measured peak % prescribed dose (%PD) and gap width below the 90% prescribed dose level (G90%) were determined to be −87% and 11.6 mm when abutting; −60% and 6.2 mm with 1.5 mm overlap; and −47% and 5.0 mm with 3.0 mm overlap. The dose profile was effectively flat with 4.5mm overlap and a peak overdosage of +34% was observed with 6.0 mm overlap. The simulated %PD and G90% were determined to be −84% and 9.5 mm when abutting; −77% and 8.2 mm with 1.0 mm overlap; −65% and 7.0 mm with 2.0 mm overlap; −45% and 5.0 mm with 3.0 mm overlap; and −17% and 2.5 mm with 4.0 mm overlap. A peak overdosage of +18% was observed with 5.0 mm overlap. Conclusion: A 5 mm plaque placement overlap provides for adequate field matching with the [formula omitted] plaque, improving its clinical utility and allowing for greater flexibility in the surgical environment.

AB - Purpose: A [formula omitted] foil in a semi‐cylindrical polycarbonate plaque has been developed and used to intraoperatively irradiate the dura for sarcomas of the spine in 16 patients. As smaller plaques are easier to place in restricted surgical fields, an investigation of field matching requirements was undertaken to evaluate the possibility of multiple site irradiations using small plaques. Method and Materials: Using a [formula omitted] brachytherapy treatment plaque and a cylindrical dosimetry phantom with the same radius, irradiations were performed using radiochromic film (GafChromic HS). 2 Gy was delivered, and the plaque was then moved to a position that would abut (0 mm) or overlap (1.5 mm, 3.0 mm, 4.5 mm, or 6.0 mm) with the previous plaque placement and an additional 2 Gy was delivered. Simulated field matching irradiations based on the plaque dose profile were also generated for 0 to 5 mm overlaps in 1 mm increments. Results: Measured peak % prescribed dose (%PD) and gap width below the 90% prescribed dose level (G90%) were determined to be −87% and 11.6 mm when abutting; −60% and 6.2 mm with 1.5 mm overlap; and −47% and 5.0 mm with 3.0 mm overlap. The dose profile was effectively flat with 4.5mm overlap and a peak overdosage of +34% was observed with 6.0 mm overlap. The simulated %PD and G90% were determined to be −84% and 9.5 mm when abutting; −77% and 8.2 mm with 1.0 mm overlap; −65% and 7.0 mm with 2.0 mm overlap; −45% and 5.0 mm with 3.0 mm overlap; and −17% and 2.5 mm with 4.0 mm overlap. A peak overdosage of +18% was observed with 5.0 mm overlap. Conclusion: A 5 mm plaque placement overlap provides for adequate field matching with the [formula omitted] plaque, improving its clinical utility and allowing for greater flexibility in the surgical environment.

UR - http://www.scopus.com/inward/record.url?scp=85024806183&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85024806183&partnerID=8YFLogxK

U2 - 10.1118/1.2760760

DO - 10.1118/1.2760760

M3 - Article

AN - SCOPUS:85024806183

VL - 34

SP - 2425

JO - Medical Physics

JF - Medical Physics

SN - 0094-2405

IS - 6

ER -